Correct. All this stuff will take at least 2x longer than

New Post Public Reply Private Reply Replies (0) Message Board
Normy CDiddy #103442
423
Correct. All this stuff will take at least 2x longer than just the math of ideal dates. It was the same for CD10 and 12. We all knew last patient was dosed then it was way way past 28 days. We had to "lock" the data, blah blah. Plus i'm guessing we have to deal with Brazil issues that we didnt have to deal with for CD10/12.

We will all probably gnash our teeth with the debate about interim analysis too. I mean we are so close to full enrollment we should just keep going to really prove to the world about LL. Well maybe not... NP is an idiot for having 40% interim when we all knew it would fill super fast. NP is a dummy for having such a large trial in a foreign country that would take forever to fill. More taste, less filling.

We will probably send stuff to them in spanish then get ignored until we realize we had to send in Portuguese. Plus the email will get stuck in spam, then somehow put in the archive folder unknowingly. I know i sent it but it isnt anywhere i can find it. I mean how can i blame NP for losing an email when its common practice for me. Maybe LL will prove dementia/alzheimer's applicable, or maybe just enough to help me remember my sunglasses are on my head and i left my wallet in the console.

LH. Everyone knows the real money is in LH and if we had only spent more time and gotten LH P3 going we would be in a better spot than chasing severe and critical. I mean NP should have known that covid cases would drop through the floor in brazil. i mean we all saw it, how could he have been so dumb. If only they had done LH in brazil we would be approved by now.

What is the status of the cancer BTD? We have awesome results! Its a slam dunk. Expect variations of this in the coming weeks.

HIV BLA. I think this is getting left on the table simply for us to have something to discuss when we get bored of covid. I mean if it was all done we'd all be swimming in the proverbial respert scrooge mcduck pond of coins and it wouldnt matter.

I would really like to see a reinvigoration of the GvHD. I mean thats been pretty quiet, with the pause of the study. Could someone volunteer to beat this drum and really make some noise so we can have something else to grouse about?

NASH. I really havent spent a bunch of time on this one and dont really understand what the big fuss its. I'm kind of a fatty, so maybe i have a fatty liver. Hopefully LL is better than a keto diet, because i'm kind of a bread guy.

I'm kinda hoping that LL has indications for general inflammation. Ohms list has a bunch of 'itis's and 'osis's on it. My damn plantar fasciitis could maybe use a shot of LL. Also my son who pitches gets a little tendonitis because he doesnt do his core exercises. Both my son and i could continue to be lazy bums and just get an occasional shot of LL and let me live the way i want.
3

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Housing Affordability Stagnant as Rates Rise

Updated Category News Views 55

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Continue Reading
Data Incident at Killingly Schools: Lessons in Security

Updated Category News Views 95

Caught off Guard in Connecticut When a school district's name crosses the ticker tape, you don't expect it to be about a data breach. But that's the hand Killingly Public Schools in Connecticut was dealt. Despite bulletproofing their systems, they found themselves up against a nasty cyber skirmish — a breach exposing personally identifiable information. Timeline of...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 118

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
FuelCell's Legal Storm Over Misleading Disclosures

Updated Category News Views 52

The Hard Sell on FuelCell's Promises FuelCell Energy, folks. If you've been anywhere near the market scene, you know their tale: promising clean energy with a side of misery for investors. Right now, the company finds itself in hot water over some murky disclosures about its business prowess—or lack thereof. A class action suit is brewing, and anyone with money tied up...

Continue Reading
Fluence Energy Faces Class Action Amid $3B Wipeout

Updated Category News Views 65

The Fluence Fiasco: From Optimism to Legal Battles One minute you're riding high on promises, the next you're grappling with losses that could sink a ship. Fluence Energy (NASDAQ: FLNC) is learning this harsh lesson, as its shareholders eye a nasty $3 billion nosedive and a fresh securities class action lawsuit to boot. Imagine thinking you're poised to tap into an...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 20

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
From Refugee to CEO: Duong's Inspiring Story

Updated Category News Views 16

From Vietnam to San Francisco: Duong's Journey The odyssey begins in the tumultuous days of 1975, when the Duong family, reeling from the fall of Saigon, fled their home country. This wasn't a round-the-corner hop; it was a leap for survival, crammed in a small boat, facing the unforgiving ocean. The documentary 'The King of Trash' transports us back to that time,...

Continue Reading
Emirates Wins 2026 Food Waste Award with Biodigester

Updated Category News Views 50

Award Goes to Emirates for Sustainable Innovations Here's a twist in the waste management narrative: Emirates Flight Catering (EKFC) snagged the Best Food Waste Initiative of the Year 2026 at none other than the Middle East Waste & Recycling Awards. It's no small feat to stand out in an arena that's buzzing with initiatives left and right. So, what's their secret weapon?...

Continue Reading
Aemetis Faces Class Action Over Wage Violation Claims

Updated Category News Views 83

California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...

Continue Reading
Class Action Looms Over Tenax Therapeutics Investors

Updated Category News Views 56

Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...

Continue Reading

Top 5 Most Recently Viewed Articles

Cullen/Frost Bankers to Share Q3 2025 Earnings Insights

Updated Category News Views 109

Cullen/Frost Bankers, Inc. Hosts Earnings Conference Call Cullen/Frost Bankers, Inc. (NYSE: CFR) is set to host an engaging conference call to discuss their financial performance for the third quarter of 2025. This event will occur on a Thursday in late October, and it comes at a time when the bank aims to inform stakeholders about its earnings for the period. Details...

Continue Reading
Rhiannon Meaden Joins Avalere Health as Strategic Lead

Updated Category News Views 182

Avalere Health Appoints Rhiannon Meaden as New Head of Strategy Avalere Health has officially announced the appointment of Rhiannon Meaden, Ph.D., as the Head of Medical Strategy and Transformation. Rhiannon's extensive experience and dedication to improving patient outcomes make her an ideal leader for Avalere's ambitious goals in the healthcare landscape. Background of...

Continue Reading
Georgia-Pacific's New VP: Will Medina Shift the Sales Game?

Updated Category News Views 286

Georgia-Pacific named Nate Medina senior vice president and general sales manager of GP PRO on February 18, 2026. Desks are buzzing over this appointment—traders are weighing how his decade-plus experience might play out for the company's bottom line. Nate Medina Takes Charge: A Game Changer or Just Another Suit? Medina’s history with Georgia-Pacific is impressive but...

Continue Reading
SmartFinancial's Earnings Outperform, Keeping Neutral Rating

Updated Category News Views 34

SmartFinancial Maintains Strong Performance Amidst Challenges Recently, Piper Sandler reaffirmed a Neutral rating on SmartFinancial (NYSE: SMBK) shares with a price target set at $28.00. The analysis highlighted that SmartFinancial exceeded earnings estimates, with earnings per share (EPS) surpassing expectations by $0.03 and the consensus by $0.08. This positive...

Continue Reading
Top High-Yield Dividend Stocks to Consider Now

Updated Category News Views 133

Top High-Yield Dividend Stocks to Consider High dividend yield stocks are capturing my attention more than ever lately. However, dividends aren't the only factor I consider; I also pay close attention to the strength of the underlying businesses and their growth potential. While there are many solid investment options available, a few particularly stand out. Here are my...

Continue Reading